Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,204 | 16,285 | 15,428 | 13,732 | 16,148 |
| Receivables | 121,373 | 124,480 | 115,103 | 109,493 | 111,499 |
| Inventories | 71,658 | 67,342 | 60,445 | 54,795 | 52,551 |
| Other current assets | 5,410 | 6,623 | 5,061 | 5,681 | 5,171 |
| TOTAL | $236,124 | $227,927 | $211,702 | $195,215 | $199,621 |
| Non-Current Assets | |||||
| PPE Net | 101,662 | 102,341 | 105,028 | 107,252 | 109,176 |
| Intangibles | 106,857 | 106,713 | 106,928 | 107,096 | 99,445 |
| Other Non-Current Assets | 157,205 | 156,636 | 154,696 | 160,627 | 169,298 |
| TOTAL | $365,724 | $365,690 | $366,652 | $374,975 | $377,919 |
| Total Assets | $601,848 | $593,617 | $578,354 | $570,190 | $577,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 39,145 | 38,366 | 45,847 | 34,343 | 36,106 |
| Accrued Expenses | 21,210 | 23,484 | 23,431 | 21,225 | 22,830 |
| Other current liabilities | 8,546 | 7,926 | 8,360 | 6,840 | 7,549 |
| TOTAL | $96,194 | $95,624 | $103,135 | $87,359 | $95,909 |
| Non-Current Liabilities | |||||
| Long Term Debt | 182,583 | 180,440 | 172,386 | 182,677 | 186,979 |
| Deferred Revenues | 5,539 | 5,952 | 5,942 | 5,760 | 6,527 |
| Other Non-Current Liabilities | 91,258 | 95,065 | 91,063 | 94,015 | 97,473 |
| TOTAL | $286,050 | $297,842 | $286,265 | $299,538 | $307,864 |
| Total Liabilities | $382,244 | $393,466 | $389,400 | $386,897 | $403,773 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,680 | 46,664 | 46,634 | 46,371 | 46,325 |
| Common Shares | 467 | 1,194 | 1,194 | 1,188 | 1,188 |
| Retained earnings | 110,234 | 87,855 | 85,949 | 79,662 | 72,601 |
| Other shareholders' equity | 873 | 867 | 557 | 114 | 199 |
| TOTAL | $219,604 | $200,151 | $188,954 | $183,293 | $173,767 |
| Total Liabilities And Equity | $601,848 | $593,617 | $578,354 | $570,190 | $577,540 |